Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

67.75%

64.90%

68.88%

66.15%

Annual Dental Visits (ADV) Total

NB

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

29.97%

46.74%

30.26%

48.16%

Appropriate Testing for Pharyngitis (CWP)

78.18%

77.56%

86.12%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

88.19%

93.08%

87.60%

91.27%

Asthma Medication Ratio (AMR) Total

61.81%

69.41%

65.35%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

58.62%

66.19%

55.75%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

59.37%

68.61%

66.91%

71.78%

Breast Cancer Screening (BCS)

53.52%

55.25%

Breast Cancer Screening (BCS-E)

53.36%

54.94%

53.03%

56.66%

Cervical Cancer Screening (CCS)

56.20%

59.85%

57.42%

60.10%

Childhood Immunization Status (CIS) Combination #10

19.95%

35.04%

23.84%

31.32%

Chlamydia Screening in Women (CHL) Total

58.78%

61.07%

60.08%

61.46%

Controlling High Blood Pressure (CBP)

55.47%

65.45%

60.58%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

80.72%

80.86%

81.90%

83.51%

Eye Exam for Patients With Diabetes (EED)

53.04%

56.20%

59.85%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

20.12%

27.73%

18.76%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

42.42%

46.35%

41.49%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

32.38%

41.03%

40.94%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

28.98%

37.31%

32.63%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

62.65%

57.90%

61.44%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

61.44%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

51.82%

55.72%

54.74%

59.64%

Immunizations for Adolescents (IMA) Combination #2

32.36%

38.93%

30.66%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

11.51%

16.94%

13.92%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

28.57%

38.80%

38.83%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

28.37%

39.01%

29.66%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

29.66%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

33.78%

31.93%

36.13%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

73.67%

75.79%

67.87%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

81.43%

86.96%

81.33%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

94.30

≤ 92.72%

91.01%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

84.91%

86.86%

86.13%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

77.86%

80.78%

76.40%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

13.38%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

13.38%

25.81%

13.77%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

2.80%

≤ 2.45%

2.81%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

82.72%

81.64%

81.75%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

64.40%

73.63%

61.09%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

66.45%

67.07%

66.91%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

56.96%

70.37%

52.72%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

57.00%

63.89%

59.56%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

66.81%

75.44%

65.46%

72.74%

Use of Opioids at High Dosage (HDO)

3.74%

≤ 2.19%

0.92%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

0.98%

≤ 0.87%

1.68%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

70.07%

83.21%

68.13%

86.20%